Related references
Note: Only part of the references are listed.Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling
Ulrich Foerstermann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension
Ji Gao et al.
JOURNAL OF HYPERTENSION (2011)
Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: A promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?
Jeremy Bellien et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Endothelial dysfunction and vascular disease
P. M. Vanhoutte et al.
ACTA PHYSIOLOGICA (2009)
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
Michael A. Weber et al.
LANCET (2009)
Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease
Pietro Minuz et al.
HYPERTENSION (2008)
Determination of epoxyeicosatrienoic acids in human red blood cells and plasma by GC/MS in the NICI mode
Sophie Goulitquer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Cytochrome P4502C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure
Dieter Fischer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence
Peter H. MacArthur et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line
Celine Bertrand-Thiebault et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients
Lorenzo Ghiadoni et al.
JOURNAL OF HYPERTENSION (2007)
Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase
David Loch et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2007)
Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation
Jeremy Bellien et al.
HYPERTENSION (2006)
Identification of a cytochrome P4502C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients
Stefano Taddei et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Plasma nitrite reserve and endothelial function in the human forearm circulation
Tienush Rassaf et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans
P Kleinbongard et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Reduction of peripheral flow reserve impairs endothelial function in conduit arteries of patients with essential hypertension
T Lauer et al.
JOURNAL OF HYPERTENSION (2005)
Inhibition of cytochrome P4502C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease
S Fichtlscherer et al.
CIRCULATION (2004)
ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humans
LE Spieker et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women
MG Modena et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Shear-induced changes in endothelin-1 secretion of microvascular endothelial cells
GX Wang et al.
MICROVASCULAR RESEARCH (2002)
Plasma endothelin-1 levels in liver cirrhosis
CM Bruno et al.
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH (2000)
Regulation of the endothelin system by shear stress in human endothelial cells
H Morawietz et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)